Biotechnology Venture Capital Firms
The world of biotechnology is one filled with unlimited potential and opportunities. Built upon transformative innovations that have the strength to redefine industries, it comes as no surprise that it stands as a powerful magnet for venture capital (VC) firms keen on investing in the future. Welcome to VC Firms List, the one-stop destination for all detailed information on biotechnology venture capital firms. As you explore, you will discover why we are the go-to website for anyone seeking insights into the VC firms and investors specializing in the biotechnology sector.
Read more
Company:
Zentynel Frontier Investments
Description: Zentynel Frontier Investments represents a significant convergence of expertise, emerging from a collaboration involving the Fundación Ciencia y Vida, alongside notable individuals such as Pablo Valenzuela, Bernardita Méndez, and Cristián Hernández, as well as Venturance Alternative Assets. This forward-thinking firm has meticulously reviewed various industries and recognized a distinct need for specialized investment in biotechnological ventures. Their efforts are primarily focused on bridging the critical investment gap that currently exists for biotechnology projects throughout Latin America.
By providing not only the necessary capital but also valuable industry experience, Zentynel Frontier Investments aims to accelerate the development and growth of biotechnological initiatives. They are dedicated to supporting entrepreneurs in the biotechnology field from the initial stages of research and local development through to execution and global marketing, thereby fostering a more robust ecosystem for innovation in this vital sector. Through their commitment, Zentynel seeks to empower local talent and enhance the global competitiveness of Latin America's biotechnology landscape.
Industry: Venture Capital and Private Equity
Founded: 2017
Domain: http://www.zentynel.com/
Location: Santiago
Address: Santiago, CL
Size: 2-10 employees
Company:
age1
Description: age1 is a distinguished venture capital firm that specializes in funding innovative companies focused on breakthroughs in the field of longevity. By identifying and investing in businesses that tackle the fundamental challenges associated with this rapidly evolving sector, age1 plays a pivotal role in promoting advancements that could significantly enhance human healthspan. The firm prides itself on collaborating with bold and contrarian founders, providing them with the support and resources necessary to build generational biotech companies. With a forward-thinking approach, age1 is committed to fostering the growth of transformative ideas that have the potential to reshape the future of longevity and biotechnology.
Company:
iCFO Capital Global, Inc.
Description: iCFO Capital Global, Inc. is an esteemed entity with over 25 years of experience in successful business financing and private equity. The company boasts a deep understanding of a diverse range of sectors, including technology, manufacturing, government contracting, telecommunications, biotechnology, and more. iCFO Capital is particularly focused on raising equity and debt capital for emerging technology companies, allowing them to thrive in an ever-evolving marketplace.
The organization is designed to create significant value for its clients through several strategic initiatives, including its Investment Conference. This conference serves as a platform for presenting investment opportunities aimed at raising capital through either debt or equity positions. Thanks to the strategic relationships cultivated by the founding management team, iCFO Capital provides its customers with a unique opportunity to network with representatives from accredited investors and notable investment firms such as Morgan Stanley, Oppenheimer & Company, Silicon Valley Bank, Oracle Capital, and those involved in clean technology.
Moreover, iCFO Capital maintains a comprehensive database that includes a vast list of investment banks and accredited investors, further enhancing their ability to connect businesses with potential funding sources.
In addition to its investment initiatives, iCFO Capital specializes in Venture Growth Debt, a specific type of financing designed for venture-backed companies. This financing option offers working capital essential for growth and development, allowing businesses to maximize their equity investments. By leveraging these facilities, companies can extend their cash runway and successfully reach critical milestones. iCFO Capital's expertise in venture debt accommodates a wide spectrum of businesses, ranging from emerging startups to mature, later-stage companies, contributing to their comprehensive approach in the capital markets.
Industry: Capital Markets
Founded: 2008
LinkedIn: https://www.linkedin.com/company/icfo_2
Domain: http://www.icfolajolla.com/
Location: La Jolla, California
Address: 4225 Executive Square Suite 600, PMB #690, La Jolla, California 92037, US
Size: 11-50 employees